This degradation increases BBB permeability, allowing inflammatory molecules and microbial metabolites to enter the brain, intensifying neuroinflammation, tau pathology, and neuronal damage, all key features of AD pathology. This evidence concerns the gene MAPT and Alzheimer disease.